Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saphire Lifesciences is an Indian pharmaceutical company specializing in the development, manufacturing, and global export of finished dosage formulations. The company operates a WHO-GMP certified manufacturing facility equipped to produce a diverse range of products, including tablets, capsules, liquid orals, and semi-solid preparations such as ointments and creams. Functioning largely as a Contract Development and Manufacturing Organization (CDMO), Saphire Lifesciences provides end-to-end services from formulation development to large-scale production for international partners. Their business model is heavily focused on the export market, supplying affordable generic medicines to emerging economies in Africa, Southeast Asia, Latin America, and the CIS region. The company maintains a broad portfolio across therapeutic areas such as anti-infectives, analgesics, and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saphire Lifesciences.